Zoltán Endre

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Marlies Ostermann, Rinaldo Bellomo, Emmanuel A. Burdmann et al. · Kidney International · 2020 · 550 citations · Full text

Medicine, Nephrology, Acute Care Medicine +10

Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference

Patrick Murray, Ravindra L. Mehta, Andrew Shaw et al. · Kidney International · 2013 · 427 citations · Full text

Medicine, Nephrology, Dialysis +13

Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)

Zoltán Endre, Robert Walker, John W. Pickering et al. · Kidney International · 2010 · 280 citations · Full text

Medicine, Nephrology, Pharmacotherapy +8

Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function

Zoltán Endre, John W. Pickering, Robert Walker et al. · Kidney International · 2011 · 280 citations · Full text

Medicine, Nephrology, Critical Care Medicine +15